Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aporphines | 14 | 2022 | 16 | 7.140 |
Why?
|
| Receptors, Dopamine D1 | 7 | 2023 | 35 | 4.290 |
Why?
|
| Structure-Activity Relationship | 21 | 2023 | 376 | 2.880 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 6 | 2016 | 16 | 2.100 |
Why?
|
| Receptors, Dopamine | 3 | 2023 | 21 | 2.090 |
Why?
|
| Receptors, Serotonin | 3 | 2020 | 21 | 2.010 |
Why?
|
| Ligands | 12 | 2023 | 317 | 1.740 |
Why?
|
| Benzazepines | 3 | 2023 | 29 | 1.720 |
Why?
|
| Dopamine Agonists | 3 | 2020 | 29 | 1.530 |
Why?
|
| Berberine | 4 | 2020 | 5 | 1.520 |
Why?
|
| Molecular Structure | 13 | 2021 | 467 | 1.440 |
Why?
|
| Dopamine Antagonists | 5 | 2023 | 39 | 1.360 |
Why?
|
| Receptors, Dopamine D3 | 4 | 2023 | 11 | 1.340 |
Why?
|
| Diterpenes | 4 | 2012 | 83 | 1.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 57 | 0.910 |
Why?
|
| Amides | 1 | 2023 | 66 | 0.900 |
Why?
|
| Xylenes | 1 | 2021 | 1 | 0.820 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2021 | 17 | 0.800 |
Why?
|
| Serotonin Antagonists | 1 | 2020 | 22 | 0.760 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2020 | 2 | 0.750 |
Why?
|
| Azepines | 1 | 2020 | 17 | 0.750 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2021 | 984 | 0.670 |
Why?
|
| Salvia | 3 | 2007 | 5 | 0.650 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2016 | 6 | 0.580 |
Why?
|
| Amines | 1 | 2016 | 38 | 0.570 |
Why?
|
| Receptors, sigma | 1 | 2016 | 16 | 0.560 |
Why?
|
| Alkaloids | 1 | 2016 | 38 | 0.550 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2011 | 13 | 0.500 |
Why?
|
| Diterpenes, Clerodane | 4 | 2007 | 4 | 0.450 |
Why?
|
| Lamiaceae | 1 | 2012 | 4 | 0.450 |
Why?
|
| Receptors, GABA-A | 1 | 2012 | 60 | 0.420 |
Why?
|
| Cocaine | 3 | 2020 | 219 | 0.410 |
Why?
|
| Humans | 17 | 2023 | 34853 | 0.380 |
Why?
|
| Acetylcholinesterase | 1 | 2010 | 53 | 0.380 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2010 | 41 | 0.370 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2009 | 8 | 0.370 |
Why?
|
| Binding Sites | 4 | 2023 | 597 | 0.360 |
Why?
|
| Furans | 2 | 2007 | 34 | 0.350 |
Why?
|
| Extinction, Psychological | 2 | 2020 | 89 | 0.320 |
Why?
|
| Caco-2 Cells | 2 | 2022 | 48 | 0.320 |
Why?
|
| Receptors, Opioid, delta | 2 | 2007 | 22 | 0.300 |
Why?
|
| Molecular Conformation | 2 | 2020 | 150 | 0.290 |
Why?
|
| Stereoisomerism | 4 | 2012 | 162 | 0.280 |
Why?
|
| Cocaine-Related Disorders | 2 | 2016 | 84 | 0.280 |
Why?
|
| Plants, Medicinal | 1 | 2006 | 54 | 0.270 |
Why?
|
| Algorithms | 2 | 2023 | 435 | 0.260 |
Why?
|
| Animals | 9 | 2020 | 14307 | 0.200 |
Why?
|
| Protein Binding | 2 | 2023 | 913 | 0.200 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2020 | 8 | 0.190 |
Why?
|
| Halogenation | 1 | 2020 | 19 | 0.190 |
Why?
|
| Proteins | 1 | 2023 | 352 | 0.180 |
Why?
|
| Hydrogen Bonding | 1 | 2020 | 119 | 0.180 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2020 | 75 | 0.180 |
Why?
|
| Reward | 2 | 2018 | 73 | 0.180 |
Why?
|
| Self Administration | 1 | 2018 | 41 | 0.160 |
Why?
|
| Models, Chemical | 2 | 2010 | 201 | 0.160 |
Why?
|
| Kinetics | 2 | 2010 | 650 | 0.160 |
Why?
|
| Cues | 1 | 2018 | 54 | 0.160 |
Why?
|
| Receptors, Opioid, kappa | 2 | 2007 | 15 | 0.150 |
Why?
|
| Models, Molecular | 2 | 2010 | 751 | 0.150 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 5 | 0.150 |
Why?
|
| Cell Line | 1 | 2020 | 1289 | 0.140 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2016 | 68 | 0.140 |
Why?
|
| Rats | 4 | 2020 | 3261 | 0.130 |
Why?
|
| HCT116 Cells | 1 | 2011 | 34 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2011 | 107 | 0.100 |
Why?
|
| Electrophorus | 1 | 2010 | 3 | 0.100 |
Why?
|
| Rhodopsin | 1 | 2010 | 36 | 0.100 |
Why?
|
| Spectrophotometry | 1 | 2010 | 71 | 0.100 |
Why?
|
| Iodobenzenes | 1 | 2009 | 2 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2010 | 97 | 0.090 |
Why?
|
| Fluoroacetates | 1 | 2009 | 2 | 0.090 |
Why?
|
| Ketanserin | 1 | 2009 | 4 | 0.090 |
Why?
|
| Trifluoroacetic Acid | 1 | 2009 | 2 | 0.090 |
Why?
|
| Appetite Depressants | 1 | 2009 | 8 | 0.090 |
Why?
|
| Cyclization | 1 | 2009 | 47 | 0.090 |
Why?
|
| CHO Cells | 2 | 2007 | 107 | 0.090 |
Why?
|
| Thermodynamics | 1 | 2010 | 207 | 0.090 |
Why?
|
| Cricetinae | 2 | 2007 | 217 | 0.090 |
Why?
|
| Receptors, Opioid, mu | 2 | 2007 | 47 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 383 | 0.090 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2010 | 117 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 181 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2009 | 81 | 0.090 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 65 | 0.090 |
Why?
|
| Cattle | 1 | 2010 | 472 | 0.080 |
Why?
|
| Carbon | 1 | 2009 | 95 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 347 | 0.080 |
Why?
|
| Drug Design | 1 | 2009 | 154 | 0.080 |
Why?
|
| Calcium | 1 | 2009 | 445 | 0.070 |
Why?
|
| Receptors, Opioid | 1 | 2006 | 50 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 881 | 0.060 |
Why?
|
| DNA | 1 | 2006 | 549 | 0.060 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 86 | 0.050 |
Why?
|
| Conditioning, Classical | 1 | 2020 | 59 | 0.050 |
Why?
|
| Mice | 1 | 2009 | 5668 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 304 | 0.040 |
Why?
|
| Locomotion | 1 | 2018 | 91 | 0.040 |
Why?
|
| Fluorenes | 1 | 2016 | 26 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 217 | 0.030 |
Why?
|
| Piperazines | 1 | 2016 | 109 | 0.030 |
Why?
|
| Male | 3 | 2020 | 18870 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1534 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1300 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2007 | 61 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 74 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 237 | 0.020 |
Why?
|
| Deuterium | 1 | 2004 | 10 | 0.020 |
Why?
|
| Body Fluids | 1 | 2004 | 15 | 0.020 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 27 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2004 | 110 | 0.020 |
Why?
|
| Hallucinogens | 1 | 2004 | 25 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2004 | 140 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 255 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2004 | 250 | 0.010 |
Why?
|